• Startseite >> 
• Gesundheit >> 
• Krebsregister >> 
• Auswertung Forschung >> 
• Veroeffentlichungen

Krebsregister

• Über uns
• Patientinnen und Patienten
• Ärztinnen und Ärzte
• Auswertungen und Forschung
  • Jahresberichte
  • Datenbank
  • Forschung
  • Veröffentlichungen
• Service

Veröffentlichungen

Veröffentlichungen

2021

• Gennari, P., M. Gerken, J. Meszaros, M. Klinkhammer-Schalke, O. Ortmann, H. Eggemann, and A. Ignatov.
  Minimal-Invasive or Open Approach for Surgery of Early Cervical Cancer: The Treatment Center Matters.
  Archives of Gynecology and Obstetrics 304, no. 2: 503-10; August 2021
• Gödde, K., Siegerink, B., Fügemann, H., Keune, D., Sander, S., Schneider, A., Müller-Nordhorn, J., Holmberg, C., Rieckmann, N., Frost, N., Keilholz, U., Goerling, U.
  Can routine register data be used to identify vulnerable lung cancer patients of suboptimal care in a German comprehensive cancer centre?
  European Journal of Cancer Care (English Language Edition) 30, no. 4: e13398; Juli 2021
• Han N, Heublein S, Jeschke U, Kuhn C, Hester A, Czogalla B, Mahner S, Rottmann M, Mayr D, Schmoeckel E, Trillsch F.
  The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
  Cells. 2021 Mar 11;10(3):619. doi: 10.3390/cells10030619. PMID: 33799631; PMCID: PMC8001910.
• Hossann, M., Hirschberger, J., Schmidt, R., Baumgartner, C., Zimmermann, K., Baer, S., Ratzlaff, C., Peller, M., Troedson, K., Limmer, S., Brühschwein, A., Dörfelt, R., Kreutzmann, N., Wess, G., Knösel, T., Schagon, O., Fischer, J., Grüll, H., Willerding, L., Schmidt, M., Meyer-Lindenberg, A., Issels, R.D., Schwaiger, M., Eggermont, A.M., ten Hagen, T.L. and Lindner, L.H. (2021)
  A Heat-Activated Drug-Delivery Platform Based on Phosphatidyl-(oligo)-glycerol Nanocarrier for Effective Cancer Treatment
  Adv. NanoBiomed Res., 1: 2000089.
• Issels, R. D., E. Noessner, L. H. Lindner, M. Schmidt, M. Albertsmeier, J. Y. Blay, E. Stutz, Y. Xu, V. Buecklein, A. Altendorf-Hofmann, S. Abdel-Rahman, U. Mansmann, M. von Bergwelt-Baildon, and T. Knoesel
  Immune Infiltrates in Patients with Localised High-Risk Soft Tissue Sarcoma Treated with Neoadjuvant Chemotherapy without or with Regional Hyperthermia: A Translational Research Program of the Eortc 62961-Esho 95 Randomised Clinical Trial.
  Euro-pean Journal of Cancer 158: 123-32; 16. Oktober 2021
• Jesinghaus, M., M. Schmitt, C. Lang, M. Reiser, A. Scheiter, B. Konukiewitz, K. Steiger, M. Sil-va, M. Tschurtschenthaler, S. Lange, S. Foersch, K. F. Becker, D. Saur, H. Friess, K. Halfter, J. Engel, M. Boxberg, N. Pfarr, D. Wilhelm, and W. Weichert
  Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria from the 2019 Who Classification in a Large Colorectal Cancer Cohort Comprising 1004 Cases.
  American Journal of Surgical Pathology 45, no. 7: 969-78; 1. Juli 2021
• Konukiewitz, B., M. Schmitt, M. Silva, J. Pohl, C. Lang, K. Steiger, K. Halfter, J. Engel, A. M. Schlitter, M. Boxberg, N. Pfarr, D. Wilhelm, S. Foersch, M. Tschurtschenthaler, W. Weichert, and M. Jesinghaus.
  Loss of Cdx2 in Colorectal Cancer Is Associated with Histopathologic Subtypes and Microsatellite Instability but Is Prognostically Inferior to Hematoxylin-Eosin-Based Morphologic Parameters from the Who Classification.
  British Journal of Cancer; 6. Oktober 2021
• Michl, M., F. Taverna, J. Kumbrink, T. S. Schiergens, V. Heinemann, J. Engel, T. Kirchner, and J. Neumann.
  Biomarker Alterations Associated with Distinct Patterns of Metastatic Spread in Colorectal Cancer.
  Virchows Archiv 478, no. 4: 695-705; April 2021
• Scharl, S., C. Becher, M. Gerken, A. Scharl, M. Anapolski, A. Ignatov, E. C. Inwald, O. Ort-mann, O. Kölbl, M. Klinkhammer-Schalke, and T. Papathemelis
  Is There a Benefit for Adju-vant Radio(Chemo)Therapy in Early Cervical Cancer? Results from a Population-Based Study
  Archives of Gynecology and Obstetrics 304, no. 3: 759-71; September 2021
• Scharl, S., M. Gerken, T. Sprötge, K. Kronberger, A. Scharl, A. Ignatov, O. Ortmann, O. Kölbl, M. Klinkhammer-Schalke, and T. Papathemelis
  Comparison of Survival Outcomes and Ef-fects of Therapy between Subtypes of High-Grade Endometrial Cancer - a Population-Based Study
  Acta Oncologica 60, no. 7: 897-903; Juli 2021
• Scharl, S., T. Sprötge, M. Gerken, A. Scharl, A. Ignatov, E. C. Inwald, O. Ortmann, O. Kölbl, M. Klinkhammer-Schalke, and T. Papathemelis
  Factors Influencing Treatment Decision and Guideline Conformity in High-Grade Endometrial Cancer Patients: A Population-Based Study
  Archives of Gynecology and Obstetrics; 5. Juli 2021
• Schrodi S., Braun M., Andrulat A., Harbeck N., Mahner S., Kiechle M., Klein E., Schnelzer A., Schindlbeck C., Bauerfeind I., Schubert-Fritschle G., Nekljudova V., Mayr D., Weichert W., Denkert C., Loibl S., Engel J.
  Outcome of breast cancer patients with low hormone receptor positivity: analysis of a 15-year population-based cohort
  Annals of Oncology; 28. September 2021; doi: 10.1016/j.annonc.2021.08.1988
• Spoerl, S., G. Spanier, E. Reiter, M. Gerken, S. Haferkamp, J. Grosse, K. Drexler, T. Ettl, M. Klinkhammer-Schalke, R. Fischer, S. Spoerl, T. E. Reichert, and C. Klingelhöffer
  Head and Neck Melanoma: Outcome and Predictors in a Population-Based Cohort Study
  Head & Face Medicine 17, no. 1: 45; 22. Oktober 2021
• Stangl S., Rauch S., Rauh J., Meyer M., Müller-Nordhorn J., Wildner M., Wöckel A., Heuschmann P.U.
  Disparities in accessibility to evidence-based breast cancer care facilities by rural and urban areas in Bavaria, Germany.
  Cancer. 2021 Jul 1;127(13):2319-2332. doi: 10.1002/cncr.33493. Epub 2021 Apr 7. PMID: 33826747.
• Thurmaier, J., V. Heinemann, J. Engel, G. Schubert-Fritschle, M. Wiedemann, N. C. Nüssler, R. Ruppert, J. Kleeff, W. Schepp, F. Löhe, M. Karthaus, J. Neumann, J. Kumbrink, F. Taverna, A. Stahler, K. Heinrich, C. B. Westphalen, J. W. Holch, T. Kirchner, and M. Michl
  Patients with Colorectal Cancer and Brain Metastasis: The Relevance of Extracranial Metastatic Pat-terns Predicting Time Intervals to First Occurrence of Intracranial Metastasis and Survival
  International Journal of Cancer 148, no. 8: 1919-27; 15. April 2021
• Trillsch, F., S. Mahner, B. Czogalla, M. Rottmann, R. Chekerov, E. I. Braicu, G. Oskay-Öczelik, P. Wimberger, R. Richter, and J. Sehouli
  Primary Platinum Resistance and Its Prognostic Im-pact in Patients with Recurrent Ovarian Cancer: An Analysis of Three Prospective Trials from the Noggo Study Group
  Journal of Gynecologic Oncology 32, no. 3: e37; Mai 2021
• Villegas, S. L., V. Nekljudova, N. Pfarr, J. Engel, M. Untch, S. Schrodi, F. Holms, H. U. Ulmer, P. A. Fasching, K. E. Weber, C. Albig, C. Heinrichs, F. Marmé, A. Hartmann, C. Hanusch, W. D. Schmitt, J. Huober, B. Lederer, M. van Mackelenbergh, H. Tesch, C. Jackisch, M. Rezai, P. Sinn, B. V. Sinn, J. Hackmann, M. Kiechle, A. Schneeweiss, W. Weichert, C. Denkert, and S. Loibl
  Therapy Response and Prognosis of Patients with Early Breast Cancer with Low Positivity for Hormone Receptors - an Analysis of 2765 Patients from Neoadjuvant Clinical Trials
  European Journal of Cancer 148: 159-70; Mai 2021
• Voigtländer, S., A. Hakimhashemi, E. C. Inwald, O. Ortmann, M. Gerken, S. J. Klug, M. Klink-hammer-Schalke, M. Meyer, and J. Müller-Nordhorn
  Auswirkungen Der Covid-19-Pandemie Auf Die Zahl Der Krebsneuerkrankungen Und Krebsbehandlungen Nach Tumorstadium in Bayern
  Deutsches Ärzteblatt 118, no. 39 (2021): 660-61
• Willvonseder, B., F. Stögbauer, K. Steiger, M. Jesinghaus, P. H. Kuhn, C. Brambs, J. Engel, H. Bronger, G. P. Schmidt, B. Haller, W. Weichert, G. Keller, A. Noske, N. Pfarr, and M. Boxberg
  The Immunologic Tumor Microenvironment in Endometrioid Endometrial Cancer in the Mor-phomolecular Context: Mutual Correlations and Prognostic Impact Depending on Molecular Al-terations
  Cancer Immunology, Immunotherapy 70, no. 6: 1679-89; Juni 2021

2020

• Albertsmeier, M., A. Altendorf-Hofmann, L. H. Lindner, R. D. Issels, E. Kampmann, H. R. Dürr, G. Schubert-Fritschle, M. K. Angele, T. Kirchner, A. A. Jungbluth, and T. Knösel
  Cancer Testis Antigens and Immunotherapy: Expression of Prame Is Associated with Prognosis in Soft Tissue Sarcoma.
  Cancers 12, no. 12; 3. Dezember 2020
• Albertsmeier, M., K. Riedl, A. J. Stephan, M. Drefs, T. S. Schiergens, J. Engel, M. K. Angele, J. Werner, and M. Guba
  Improved Survival after Resection of Colorectal Liver Metastases in Patients with Unresectable Lung Metastases.
  HPB 22, no. 3: 368-75; März 2020
• Bielska-Lasota, M., S. Rossi, M. Krzyzak, A. Haelens, A. Domenic, R. De Angelis, A. Maciejczyk, M. Rodriguez-Barranco, V. Zadnik, P. Minicozzi, and Eurocare- Working Group
  Reasons for Low Cervical Cancer Survival in New Accession European Union Countries: A Eurocare-5 Study.
  Archives of Gynecology and Obstetrics 301, no. 2: 591-602. Februar 2020
• Czogalla, B., Pham, D., Trillsch, F., Rottmann, M., Gallwas, J., Burges, A., Mahner, S., Kirchner, T., Jeschke, U., Mayr, D. & Schmoeckel, E. (2020).
  PD‑L1 expression and survival in p16‑negative and ‑positive squamous cell carcinomas of the vulva.
  Journal of Cancer Research and Clinical Oncology, 146(3), 569-577.
  
• De Toni, E. N., A. Schlesinger-Raab, M. Fuchs, W. Schepp, U. Ehmer, F. Geisler, J. Ricke, P. Paprottka, H. Friess, J. Werner, A. L. Gerbes, J. Mayerle, and J. Engel
  Age Independent Sur-vival Benefit for Patients with Hepatocellular Carcinoma (Hcc) without Metastases at Diagno-sis: A Population-Based Study.
  Gut 69, no. 1: 168-76; Januar 2020
• Ditsch, N., Heublein, S., Jeschke, U., Sattler, C., Kuhn, C., Hester, A., Czogalla, B., Trillsch, F., Mahner, S., Engel, J., Mayr, D. & Schmoeckel, E. (2020).
  Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients.
  Journal of Cancer Research and Clinical Oncology, 146, no. 8:1923–1932
  
• Finke, I., Behrens, G., Schwettmann, L., Gerken, M., Pritzkuleit, R., Holleczek, B., Brenner, H., Jansen, L., & German Cancer Survival Working Group.
  Socioeconomic differences and lung cancer survival in Germany: Investigation based on population-based clinical cancer registration.
  Lung Cancer, 142, 1–8; April 2020
  
• Gödde, K., Fügemann, H., Müller-Nordhorn, J., Grimberg, M., Goerling, U., Siegerink, B., Rieckmann, N., Holmberg, C.
  Strukturierte Erfassung von Unterstützungsangeboten für Lungenkrebs- und Schlaganfallbetroffene in Berlin [Structured Collection of Data on Support Offers for Lung Cancer and Stroke Patients in Berlin].
  Gesundheitswesen; 12. August 2020
• Grundmann, N., Meisinger, C., Trepel, M., Müller-Nordhorn, J., Schenkirsch, G., Linseisen, J.
  Trends in cancer incidence and survival in the Augsburg study region-results from the Augsburg cancer registry.
  BMJ Open 10, no. 8: e036176; 30. August 2020
• Han, N., Jeschke, U., Kuhn, C., Hester, A., Czogalla, B., Mahner, S., Rottmann, M., Mayr, D., Schmoeckel, E., & Trillsch, F.
  H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology.
  International Journal of Molecular Sciences, 21(6), 2151; 20. März 2020
  
• Jansen, L., Behrens, G., Finke, I., Maier, W., Gerken, M., Pritzkuleit, R., Holleczek, B., Brenner, H., & German Cancer Survival Working Group (May 2020).
  Area-Based Socioeconomic Inequalities in Colorectal Cancer Survival in Germany: Investigation Based on Population-Based Clinical Cancer Registration.
  Frontiers in Oncology, 10, 857.
  
• Papathemelis, T., Oppermann, H., Grafl, S., Gerken, M., Pauer, A., Scharl, S., Scharl, A., Inwald, E., Ignatov, A., Ortmann, O., Klinkhammer-Schalke, M., Hein, A., Beckmann, M. W. & Lux, M. P. (2020).
  Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. Open procedure.
  Journal of Cancer Research and Clinical Oncology, 146(4), 961-969.
  
• Prantl, L., Gerken, M., Zeman, F., Leitzmann, M., Koller, M., Klinkhammer-Schalke, M., Evert, M., Kuehlmann, B. & Biermann, N (2020).
  Incidence of Anaplastic Large Cell Lymphoma and Breast-Implant-Associated Lymphoma—An Analysis of a Certified Tumor Registry over 17 Years.
  Journal of Clinical Medicine, 9(5), 1247.
  
• Schmuck, R., M. Gerken, E. M. Teegen, I. Krebs, M. Klinkhammer-Schalke, F. Aigner, J. Pratschke, B. Rau, and S. Benz
  Gender Comparison of Clinical, Histopathological, Therapeu-tic and Outcome Factors in 185,967 Colon Cancer Patients
  Langenbecks Archives of Surgery 405, no. 1: 71-80; Februar 2020
• Schnitzbauer, V., M. Gerken, S. Benz, V. Völkel, T. Draeger, A. Fürst, and M. Klinkhammer-Schalke
  Laparoscopic and Open Surgery in Rectal Cancer Patients in Germany: Short and Long-Term Results of a Large 10-Year Population-Based Cohort.
  Surgical Endoscopy 34, no. 3: 1132-41; März 2020
• Schultze, M., Müller-Nordhorn, J., Holmberg, C.
  Discussing the effects of prostate cancer beyond biographical disruption and new normalcy: the experiences of men with prostate cancer in Germany.
  Sociol Health Illn, 42, 1359-1378
• Spanier, G., Böttcher, J., Gerken, M., Fischer, R., Roth, G., Lehn, P., Klingelhöffer, C., Meier, J. K., Fraccaroli, A., Tischer, J., Ettl, T., Klinkhammer-Schalke, M., Reichert, T. E. & Spoerl, S.
  Prognostic value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinoma.
  Oral Oncology, 107, 104773.
  
• Spoerl, S., M. Gerken, R. Fischer, A. Mamilos, S. Spoerl, S. Wolf, F. Pohl, C. Klingelhöffer, T. Ettl, T. E. Reichert, and G. Spanier
  Lymphatic and Vascular Invasion in Oral Squamous Cell Carcinoma: Implications for Recurrence and Survival in a Population-Based Cohort Study
  Oral Oncology 111: 105009; Dezember 2020
• Spoerl, S., Gerken, M., Mamilos, A., Fischer, R., Wolf, S., Nieberle, F., Klingelhöffer, C., Meier, J. K., Spoerl, S., Ettl, T., Reichert, T. E. & Spanier, G. (2020).
  Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
  Clinical Oral Investigations.
  
• Stangl, S., K. Haas, F. A. Eichner, A. Grau, U. Selig, T. Ludwig, T. Fehm, T. Stüber, A. Rashid, A. Kerscher, R. Bargou, S. Hermann, V. Arndt, M. Meyer, M. Wildner, H. Faller, M. G. Schrau-der, M. Weigel, U. Schlembach, P. U. Heuschmann, and A. Wöckel
  Development and Proof-of-Concept of a Multicenter, Patient-Centered Cancer Registry for Breast Cancer Patients with Metastatic Disease-the "Breast Cancer Care for Patients with Metastatic Disease" (Bre-4-Med) Registry
  Pilot Feasibility Stud 6: 11;
• Taubenhansl, C., Ortmann, O., Gerken, M., Inwald, E.C. und Klinkhammer-Schalke, M.
  Guideline-concordant chemotherapy in patients with hormone receptor-positive and node-positive, early breast cancer leads to better overall and metastases-free survival with limited benefit in elderly patients.
  Archives of Gynecology and Obstetrics 301 (2), S. 573-583.
• Teufel A, Gerken M, Fürst A, Ebert M, Hohenthanner I, Klinkhammer-Schalke M.
  Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer.
  Eur J Cancer. 2020 Sep;137:148-160. doi: 10.1016/j.ejca.2020.06.036. Epub 2020 Aug 7. PMID: 32777714.
• Trillsch, F., Mahner, S., Czogalla, B., Rottmann, M., Chekerov, R., Braicu, E. I., Oskay-Öczelik, G., Wimberger, P., Richter, R. & Sehouli, J.
  Primary platinum resistance and its prognostic impact in patients with recurrent ovarian cancer: an analysis of three prospective trials from the NOGGO study group.
  J Gynecol Oncol. 2021 May;32(3):e37. doi: 10.3802/jgo.2021.32.e37. PMID: 33825355; PMCID: PMC8039167.

2019

• Bösch, F., K. Brüwer, A. Altendorf-Hofmann, C. J. Auernhammer, C. Spitzweg, C. B. Westpha-len, S. Boeck, G. Schubert-Fritschle, J. Werner, V. Heinemann, T. Kirchner, M. Angele, and T. Knösel
  Immune Checkpoint Markers in Gastroenteropancreatic Neuroendocrine Neoplasia.
  Endocrine-Related Cancer 26, no. 3: 293-301. 1. März 2019
• Draeger, T., V. Völkel, V. Schnitzbauer, M. Gerken, S. Benz, M. Klinkhammer-Schalke, and A. Fürst.
  Laparoscopic and Open Resection of Rectal Cancer-Is Age an Effect Modifier for Short- and Long-Term Survival?
  International Journal of Colorectal Disease 34, no. 5: 821-28; Mai 2019
• Elmasry, M., L. Brandl, J. Engel, A. Jung, T. Kirchner, and D. Horst.
  Rbp7 Is a Clinically Prog-nostic Biomarker and Linked to Tumor Invasion and Emt in Colon Cancer.
  Journal of Cancer 10, no. 20: 4883-91
• Gatta, G., A. Trama, R. Capocaccia, and R. ARECARENet Working Group.
  Epidemiology of Rare Cancers and Inequalities in Oncologic Outcomes.
  European Journal of Surgical Oncolo-gy 45, no. 1: 3-11; Januar 2019
• Imbimbo, M., J. M. Maury, M. Garassino, N. Girard, and R. ARECAREnet Working Group.
  Mesothelioma and Thymic Tumors: Treatment Challenges in (Outside) a Network Setting.
  European Journal of Surgical Oncology 45, no. 1: 75-80; Januar 2019
• Lauseker, M., K. Bachl, A. Turkina, E. Faber, W. Prejzner, U. Olsson-Strömberg, M. Baccarani, E. Lomaia, D. Zackova, G. Ossenkoppele, L. Griskevicius, G. Schubert-Fritschle, T. Sacha, S. Heibl, P. Koskenvesa, A. Bogdanovic, R. E. Clark, J. Guilhot, V. S. Hoffmann, J. Hasford, A. Hochhaus, and M. Pfirrmann Prognosis of Patients with Chronic Myeloid Leukemia Present-ing in Advanced Phase Is Defined Mainly by Blast Count, but Also by Age, Chromosomal Aber-rations and Hemoglobin.
  American Journal of Hematology 94, no. 11: 1236-43; November 2019
• Lykoudis, P. M., S. Partelli, F. Muffatti, M. Caplin, M. Falconi, G. K. Fusai, and R. ARECARENet Working Group.
  Treatment Challenges in and Outside a Specialist Network Setting: Pancreatic Neuroendocrine Tumours.
  European Journal of Surgical Oncology 45, no. 1: 46-51; Januar 2019
• Nicolai, N., D. Biasoni, M. A. Catanzaro, M. Colecchia, A. Trama, and R. ARECAREnet Work-ing Group.
  Testicular Germ-Cell Tumours and Penile Squamous Cell Carcinoma: Appropriate Management Makes the Difference.
  European Journal of Surgical Oncology 45, no. 1: 60-66; Januar 2019
• Orlandi, E., S. Alfieri, C. Simon, A. Trama, L. Licitra, and R. ARECAREnet Working Group.
  Treatment Challenges in and Outside a Network Setting: Head and Neck Cancers.
  European Journal of Surgical Oncology 45, no. 1: 40-45; Januar 2019
• Papathemelis, T., S. Knobloch, M. Gerken, A. Scharl, M. Anapolski, A. Ignatov, E. C. Inwald, O. Ortmann, S. Scharl, and M. Klinkhammer-Schalke
  Impact of Nodal Status and Treatment Strategy on Overall Survival in Advanced Stage Cervical Cancer.
  Journal of Cancer Research and Clinical Oncology 145, no. 5: 1369-76; Mai 2019
• Pasquali, S., S. Bonvalot, D. Tzanis, P. G. Casali, A. Trama, A. Gronchi, and R. ARECARENet Working Group
  Treatment Challenges in and Outside a Network Setting: Soft Tissue Sarcomas.
  European Journal of Surgical Oncology 45, no. 1: 31-39; Januar 2019
• Pölcher, M., Rottmann, M., Brugger, S., Mahner, S., Dannecker, C., Kiechle, M., Brambs, C., Grab, D., Anthuber, C., von Koch, F., Schnelzer, A. & Engel, J. (2019).
  Lymph node dissection in endometrial cancer and clinical outcome: A population-based study in 5546 patients.
  Gynecologic Oncology, 154(1), 65-71.
  
• Radespiel-Tröger, M., Voigtländer, S., Meyer, M., Müller-Nordhorn, J., Behringer, J., Schöfl, C., & Hollederer, A. (2019).
  Assoziation zwischen Häufigkeit der Sonographie und Prävalenz bösartiger Neubildungen der Schilddrüse bei Versicherten der AOK in Bayern.
  Der Onkologe, 25(7), 559-568.
  
• Ray-Coquard, I., A. Trama, M. J. Seckl, C. Fotopoulou, P. Pautier, S. Pignata, G. Kristensen, G. Mangili, H. Falconer, L. Massuger, J. Sehouli, E. Pujade-Lauraine, D. Lorusso, F. Amant, E. Rokkones, I. Vergote, J. A. Ledermann, and R. ARECARENet Working Group
  Rare Ovarian Tumours: Epidemiology, Treatment Challenges in and Outside a Network Setting
  European Journal of Surgical Oncology 45, no. 1: 67-74; Januar 2019
• Schmoeckel, E., Hofmann, S., Fromberger, D., Rottmann, M., Luthardt, B., Burges, A., Jeschke, U., Kirchner, T., Lax, S. F. & Mayr, D. (2019). Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic facors in ovarian carcinoma.
  Virchows Archiv, 474(5), 599-608.
  
• Völkel V, Draeger T, Schnitzbauer V, Gerken M, Benz S, Klinkhammer-Schalke M, Fürst A.
  Surgical treatment of rectal cancer patients aged 80 years and older-a German nationwide analysis comparing short- and long-term survival after laparoscopic and open tumor resection.
  European Journal of Surgical Oncology 45, no. 9: 1607-12; September 2019
• Wimmer T, Ortmann O, Gerken M, Klinkhammer-Schalke M, Koelbl O, Inwald EC.
  Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registry.
  Archives of Gynecology and Obstetrics 299, no. 4: 1131-40; April 2019

2018

• Blödt S, Kaiser M, Adam Y, Adami S, Schultze M, Müller-Nordhorn J, Holmberg C.
  Understanding the role of health information in patients’ experiences: secondary analysis of qualitative narrative interviews with people diagnosed with cancer in Germany.
  BMJ Open, 8, e019576.
• Corradini, S., Pazos, M., Schönecker, S., Reitz, D., Niyazi, M., Ganswindt, U., Schrodi, S., Braun, M., Pölcher, M., Mahner, S., Harbeck, N., Engel, J. & Belka, C. (2018).
  Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 cases.
  Radiation Oncology, 13(1), 25.
  
• Heckl, M., Schmoeckel, E., Hertlein, L., Rottmann, M., Jeschke, U. & Mayr, D. (2018).
  The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
  PLoS One, 13(2), e0192881.
  
• Weiss, M., Sim, D. A., Herold, T., Schumann, R. G., Liegl, R., Kern, C., Kreutzer, T., Schiefelbein, J., Rottmann, M., Priglinger, S. & Kortuem, K. U. (2018).
  Compliance and Adherence of Patients with Diabetic Macular Edema to Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Daily Practice.
  Retina, 38(12), 2293-2300.
  
• Würstlein, R., Hesse, A., König, A., Schulte-Vorwick, F., Schrodi, S., Ditsch, N., Mahner, S. & Harbeck, N. (2018).
  Tastbefund an der Brust: Auch bei Männern immer abklären!
  Gynäkologie + Geburtshilfe, 23, 25-27.
  

2017

• Bastiaannet, E., Charman, J., Johannesen, T. B., Schrodi, S., Siesling, S., van Eycken, L., Walsh, P. M., Audisio, R. A., Boelens, P. G., Rubio, I. T., Jones, N., Lewis, J. & van de Velde, C. J. H.
  A European, Observational Study of Endocrine Therapy Administration in Patients with an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.
  Clinical Breast Cancer, 18(4), e613-e619.
  
• Engler J, Güthlin C, Dahlhaus A, Kojima E, Müller-Nordhorn J, Weißbach L, Holmberg C.
  Physician cooperation in outpatient cancer care. An amplified secondary analysis of qualitative interview data.
  Eur J Cancer Care, 26.
• Giesler JM, Keller B, Repke T, Leonhart R, Weis J, Muckelbauer R, Rieckmann N, Müller-Nordhorn J, Lucius-Hoene G, Holmberg C.
  Effect of a Website That Presents Patients‘ Experiences on Self-Efficacy and Patient Competence of Colorectal Cancer Patients: Web-Based Randomized Controlled Trial.
  J Med Internet Res, 19, e334.
• Rottmann, M., Burges, A., Mahner, S., Anthuber, C., Beck, T., Grab, D., Schnelzer, A., Kiechle, M., Mayr, D., Pölcher, M., Schubert-Fritschle, G., & Engel J. (2017).
  Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes.
  Journal of Cancer Research and Clinical Oncology, 143(9), 1833-1844.
• Schmoeckel, E., Odai-Afotey, A. A., Schleißheimer, M., Rottmann, M., Flesken-Nikitin, A., Ellenson, L. H., Kirchner, T., Mayr, D. & Nikitin, A. Y. (2017).
  LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions.
  Modern Pathology, 30(9), 1241-1250.
• Twardella, D., Geiss, K., Radespiel-Tröger, M., Benner, A., Ficker, J.H., & Meyer, M.
  Trends der Lungenkrebsinzidenz nach histologischem Subtyp bei Männern und Frauen in Deutschland. Analyse von Krebsregisterdaten unter Einsatz von multipler Imputation.
  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 61(1), 20-31.y
  11/2017

2016

• Engler J, Adami S, Adam Y, Keller B, Repke T, Fügemann H, Lucius-Hoene G, Müller-Nordhorn J, Holmberg C. (2016).
  Using others‘ experiences. Cancer patients’ expectations and navigation of a website providing narratives on prostate, breast and colorectal cancer.
  Patient Educ Couns, 99, 1325-1332.

2015

• Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Stabenow R, Froehner M, Huber J
  Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011
  Radiotherapy and Oncology 2015, Vol. 115 (1), 90-95
  
• Keller AK, Uter W, Pfahlberg AB, Radespiel-Tröger M, Mayer I, Gefeller O.
  Replacing surrogate measures by direct quantification of ultraviolet radiation exposure in registry-based analyses of seasonality of melanoma diagnoses.
  Melanoma Res. 2015 Dec;25(6):543-9.
  

2014

• Nennecke A, Geiss K, Hentschel S, Vettorazzi E, Jansen L, Eberle A, Holleczek B, Gondos A, Brenner H, and the GEKID cancer survival working group
  Survival of cancer patients in urban and rural areas of Germany - a comparison.
  Cancer Epidemiology 2014; DOI: 10.1016/j.canep.2014.02.011.
  
• Radespiel-Tröger M, Batzler WU, Holleczek B, Luttmann S, Pritzkuleit R, Stabenow R, Urbschat I, Zeissig SR, Meyer M. Im Namen der Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (GEKID)
  Inzidenzzunahme des papillären Schilddrüsenkarzinoms in Deutschland
  Bundesgesundheitsbl 2014 · 57:84–92
  

2013

• Geiss K, Meyer M.
  A Windows application for computing standardized mortality ratios and standardized incidence ratios in cohort studies based on calculation of exact person-years at risk
  Comput Methods Programs Biomed 2013; DOI: 10.1016/j.cmpb.2013.05.028.
  
• Schrodi S, Braisch U, Schenkirsch G, Maisel T, Petsch S, Hölzel D, Klinkhammer-Schalke M, Mäder U, Schuller L, Heywang-Köbrunner SH, Meyer M, Engel J.
  Veränderungen der Therapie des Mammakarzinoms in Bayern seit Einführung des Mammografie-Screenings. Eine Analyse bayerischer Krebsregisterdaten der Jahre 2000 bis 2008
  Senologie 2013; 10: 225-235
  

2012

• Braisch U, Geiss K, Radespiel-Tröger M, Meyer M.
  Population-Based Effects of Mammography Screening in Bavaria on the Distribution of TNM-T Categories with Respect to Different Histological Subgroups
  Breast Care 2012;7:303-309
  
• Braisch U, Meyer M, Radespiel-Tröger M.
  Risk of subsequent primary cancer among prostate cancer patients in Bavaria, Germany.
  Eur J Cancer Prev. 2012 Mar 17. [Epub ahead of print]
  
• Braisch U, Meyer M, Radespiel-Tröger M
  Risk of tobacco-related multiple primary cancers in Bavaria, Germany
  BMC Cancer 2012, 12:250 doi:10.1186/1471-2407-12-250
  
• Kuznetsov L, Maier W, Hunger M, Meyer M, Mielck A.
  Regional deprivation in Bavaria, Germany: linking a new deprivation score with registry data for lung and colorectal cancer.
  Int J Public Health. 2012 Feb 8. [Epub ahead of print]
  
• Nennecke A, Barnes B, Brenner H, Eberle A, Emrich K, Eisemann N, Geiss K, Hentschel S, Holleczek B, Kraywinkel K, Stabenow R, Hense HW.
  Datenqualität oder Unterschiede in der onkologischen Versorgung? - Berichtsstandards für Überlebenszeitanalysen mit Krebsregisterdaten
  Ein Vorschlag der Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V.
  Gesundheitswesen DOI: 10.1055/s-0032-1311622
  
• Radespiel-Tröger M, Meyer M.
  Association between drinking water uranium content and cancer risk in Bavaria, Germany
  Int Arch Occup Environ Health. 2012 Sep 6. [Epub ahead of print]
  
• Radespiel-Tröger M, Meyer M, Fenner M.
  Geographic differences and time trends of intraoral cancer incidence and mortality in Bavaria, Germany.
  J Craniomaxillofac Surg. 2012 Feb 17. [Epub ahead of print]
  

2011

• Kuznetsov L, Maier W, Hunger M, Meyer M, Mielck A.
  Associations between regional socioeconomic deprivation and cancer risk: Analysis of population-based Cancer Registry data from Bavaria, Germany.
  Prev Med. 2011 Oct;53(4-5):328-30. Epub 2011 Aug 5.
  
• Radespiel-Tröger, M.
  Review: Epidemiology of cancer diseases of the kidneys, urinary tract and bladder
  [Übersicht Epidemiologie von Krebserkrankungen der Nieren, ableitenden Harnwege und Harnblase]
  Tumor Diagnostik und Therapie 2011,32:250-255.
  
• Radespiel-Tröger M:
  Berufliche UV-Belastung und Hautkrebs.
  Zbl Arbeitsmed 61 (2011), 112-125
  

2010

• Katalinic A, Emrich K,Luttmann S, Holleczek B, Stabenow R, Urbschat I, Meyer M:
  Häufigkeiten, Trends und regionale Unterschiede von Krebserkrankungen in Deutschland.
  Prävention - Zeitschrift für Gesundheitsförderung 2010, 33 (4), 99-102
  
• Nennecke A, Brenner H, Eberle A, Geiss K, Holleczek B, Kieschke J, Kraywinkel K, GEKID-Arbeitsgruppe "Überlebenszeitanalyse":
  Überlebenschancen von Krebspatienten in Deutschland - auf dem Weg zu repräsentativen, vergleichbaren Aussagen
  Gesundheitswesen 2010; 72(10): 692-699
  

2009

• Geiss K, Meyer M, Radespiel-Tröger M, Gefeller O.:
  SURVSOFT-Software for nonparametric survival analysis.
  Comput Methods Programs Biomed. 2009 Oct;96(1):63-71.
  
• Meyer M, Opitz T, Caselmann WH, Schenkirsch G, Maisel T, Petsch S, Engel J,
  Schubert-Fritschle G, Klinkhammer-Schalke M, Mäder U, Göbel-Lissowsky M, Hölzel D:
  Zehn Jahre Krebsregistrierung in Bayern.
  Gesundheitswesen 2009; 71: 293 - 298
  
• Radespiel-Tröger M, Meyer M, Pfahlberg A, Lausen B, Gefeller O:
  Outdoor work and skin cancer incidence: a registry based study in Bavaria.
  Int Arch Occup Environ Health (2009) 82:357-363
  
• Staykov D, Radespiel-Tröger M, Meyer M, Petsch S, Schwab S and Handschu R:
  Birth Month and Risk of Glioma in Adults: A Registry-Based Study in Bavaria.
  Chronobiology International (2009),26:2,282-292
  

2008

• Radespiel-Tröger M, Geiss K, Gärtig-Daugs A, Meyer M:
  Registration completeness and tumour-node-metastases category distribution in prostatic and testicular cancer in Bavaria.
  European Journal of Cancer Prevention 2008, 17:230-237
  

2006

• Meyer M, Gärtig-Daugs A, Radespiel-Tröger M:
  Mobilfunkbasisstationen und Krebshäufigkeit in Bayern
  Umweltmedizin in Forschung und Praxis 11 (2) S. 89-97 (2006),
  Ecomed Medizin, Verlagsgruppe Hüthig Jehle Rehm GmbH, Landsberg
  
• Meyer M, Gärtig-Daugs A, Radespiel-Tröger M:
  Regionale Unterschiede der Krebsmortalität in Bayern
  Zeitschrift für Bevölkerungswissenschaft, Jg. 31, 2/2006, S. 231-256, Verlag für Sozialwissenschaften, Wiesbaden
  

Vorträge und Poster

2021

Qualitätskonferenz des Bayerischen Krebsregisters

• PD Dr. med. Antoniu-Oreste Gostian
  Universitätsklinikum Erlangen - Hals-Nasen-Ohren-Klinik, Kopf und Halschirurgie
  Tumortherapie im Kopf-Hals-Bereich
• Prof. Dr. med. Andreas Mackensen, Prof. Dr. med. Stefan Krause
  Universitätsklinikum Erlangen - Medizinische Klinik 5 -Hämatologie & Internistische Onkologie
  Akute myeloische Leukämie - welche Daten brauchen wir für die Qualitätsbeurteilung?
• Dr. Martin Meyer
  Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit - Zentralstelle für Krebsfrüherkennung und Krebsregistrierung
  Vollständigkeitsanalyse Kopf-Hals-Tumoren/Leukämien
• Prof. Dr. Jacqueline Müller-Nordhorn
  Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit - Landesinstitut Bayerisches Krebsregister
  Auswirkungen der COVID-19 Pandemie auf Diagnostik und Therapie von Krebserkrankungen in Bayern

2011

• Geiss K, Braisch U, Schrodi S, Schenkirsch G, Maisel T, Petsch S, Klinkhammer-Schalke M, Mäder U, Hölzel D, Heywang-Köbrunner, Engel J, Meyer M
  Bevölkerungsbezogene Auswirkungen des Mammographie- Screenings in Bayern auf die Verteilung der Tumorstadien in Bezug auf verschiedene histologische Untergruppen
  Poster zur 31. Jahrestagung der Deutschen Gesellschaft für Senologie, Dresden, Juni 2011
  
• Meyer M:
  Automatisches Best-of - Datenbankimplementierung des Lokalisationsbaums.
  Vortrag bei der 19. Informationstagung Tumordokumentation der klinischen und epidemiologischen Krebsregister, Bayreuth, 30.3.2011
  

2005

• Meyer M, Gärtig-Daugs A, Radespiel-Tröger M:
  Krebsinzidenz im Umkreis von Mobilfunkbasisstationen (PDF-Datei 300 kB)
  Poster zur 12. Jahrestagung der Deutschen Arbeitsgemeinschaft für Epidemiologie und der 50. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie, Freiburg, September 2005
  

2004

• Daugs A:
  Epidemiologische Grundbegriffe (PDF-Datei 215 kB)
  Interner Fortbildungsvortrag, Tumorzentrum Erlangen-Nürnberg, Januar 2004
  
• Gärtig-Daugs A, Radespiel-Tröger M, Meyer M:
  Simulationsmodell zur Unterstützung der Risikokommunikation in der Krebsepidemiologie (PDF-Datei 794 kB)
  Vortrag zur 49. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie, Innsbruck, September 2004
  
• Meyer M, Radespiel-Tröger M, Petsch S, Schick S, Friedrich M:
  Epidemiologische Krebsregistrierung: Maßnahmen zur Erreichung einer hohen Datenqualität (PDF-Datei 570 kB)
  Poster zum Deutschen Krebskongress, Berlin, Februar/März 2004
  
• Radespiel-Tröger M, Daugs A, Meyer M:
  Simulation model for visualisation of small-area cancer incidence rates (PDF-Datei 1013 kB)
  Poster zur 11. Jahrestagung der Deutschen Arbeitsgemeinschaft für Epidemiologie, Heidelberg, März 2004
  

2003

• Meyer M, Radespiel-Tröger M, Vogel C:
  Record-Linkage mit anonymisierten Krebsregistermeldungen (PDF-Datei 651 kB)
  Vortrag beim 4. Workshop Krebsregister, Regensburg, April 2003
  

2000

• Meyer M, Franzkowiak de Rodriguez M, Land M:
  Automatic Validity and Consistency Check of Cancer Incidence Data using an SQL-based Dictionary (PDF-Datei 298 kB)
  Poster zur Tagung "Medical Informatics Europe 2000", Hannover, September 2000